A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye
Condition(s):Dry EyeLast Updated:October 11, 2013Withdrawn
Hide Studies Not Open or Pending
Condition(s):Dry EyeLast Updated:October 11, 2013Withdrawn
Condition(s):Dry Eye SyndromesLast Updated:January 5, 2024Active, not recruiting
Condition(s):Dry Eye SyndromesLast Updated:April 20, 2023Completed
Condition(s):Dry EyeLast Updated:April 27, 2016Completed
Condition(s):Corneal Epithelium DefectLast Updated:March 7, 2016Completed
Condition(s):Nasolacrimal Duct Obstruction; Thyroid CancerLast Updated:October 18, 2023Recruiting
Condition(s):Thyroid Carcinoma; Radioactive Iodine LevelLast Updated:January 18, 2024Terminated
Condition(s):Dry EyeLast Updated:April 3, 2020Completed
Condition(s):Keratoconjunctivitis Due to Adenovirus; Viral SheddingLast Updated:February 28, 2018Completed
Condition(s):Pain; Intravitreal Injection; Pain, AcuteLast Updated:February 9, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.